BW
NVO

BIP Wealth’s Novo Nordisk NVO Stock Holding History

BIP Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,288
Closed -$238K – 457
2025
Q3 		$238K Buy
4,288
+795
+23% +$46.5K 0.01% 274
2025
Q2 		$241K Sell
3,493
-149
-4% -$10.1K 0.01% 237
2025
Q1 		$253K Hold
3,642
– – 0.02% 231
2024
Q4 		$313K Buy
3,642
+138
+4% +$14.9K 0.02% 202
2024
Q3 		$417K Sell
3,504
-26
-0.7% -$3.47K 0.03% 150
2024
Q2 		$504K Buy
3,530
+26
+0.7% +$3.44K 0.04% 114
2024
Q1 		$450K Buy
3,504
+1,202
+52% +$143K 0.03% 130
2023
Q4 		$238K Sell
2,302
-150
-6% -$14.8K 0.02% 174
2023
Q3 		$223K Buy
+2,452
New +$216K 0.02% 161

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIP Wealth's NVO Position: Q4 2025 in Review

BIP Wealth sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,288 shares — an estimated $238K sold.

BIP Wealth first reported a position in NVO in Q3 2023 and held it in 9 quarters. The position peaked at $504K in Q2 2024. 1,416 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • BIP Wealth reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • BIP Wealth sold 4,288 Novo Nordisk shares in Q4 2025, an estimated $238K.
  • BIP Wealth first reported a position in Novo Nordisk in Q3 2023 and held it in 9 quarters.
  • BIP Wealth's Novo Nordisk position peaked at $504K in Q2 2024.
  • 1,416 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on BIP Wealth's 13F filing for Q4 2025, filed 21 Jan 2026.